Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Earnings for Rigel Pharmaceuticals (RIGL)
Earnings in 2023 (TTM): -$18.22 M
According to Rigel Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$18.22 M. an increase over its 2022 earnings that were of -$54.87 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Rigel Pharmaceuticals from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$18.22 M | -66.79% |
| 2022 | -$54.87 M | 340.73% |
| 2021 | -$12.45 M | -56.15% |
| 2020 | -$28.4 M | -57.34% |
| 2019 | -$66.56 M | -7.66% |
| 2018 | -$72.08 M | -9.47% |
| 2017 | -$79.62 M | 24.46% |
| 2016 | -$63.98 M | 23.63% |
| 2015 | -$51.75 M | -43.29% |
| 2014 | -$91.25 M | 2.5% |
| 2013 | -$89.03 M | |
| 2010 | $37.85 M | -133.97% |
| 2009 | -$0.12 B | -18.49% |
| 2008 | -$0.14 B | 71.91% |
| 2007 | -$79.53 M | 84.74% |
| 2006 | -$43.05 M | -10.17% |
| 2005 | -$47.93 M | -15.73% |
| 2004 | -$56.87 M | 39.29% |
| 2003 | -$40.83 M | 10.3% |
| 2002 | -$37.02 M | 48.3% |
| 2001 | -$24.97 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $7.85 B | -43,214.33% | 🇺🇸 USA |
 AstraZeneca AZN | $9.08 B | -49,943.57% | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | -$0.12 B | 553.12% | 🇺🇸 USA |
 ChemoCentryx CCXI | -$0.14 B | 616.83% | 🇺🇸 USA |